CEO Steve MacMillan leads charge for a global ''what gets measured gets results'' tool.

NEWARK, DE / ACCESSWIRE / March 6, 2023 / With a projected Fungus Testing Kits Market size of over US$ 1.72 billion as of 2023, the global fungus testing equipment market is to expand significantly between 2023 and 2033, growing at a rate of 10.1% CAGR and achieving US$ 4504 million by 2033. Diagnostic laboratories are to command a sizeable market share of more than 51.8% in 2023, according to Future Market Insights'' predictions. FMI conducted a comparative analysis of market growth rates and future opportunities in the global fungus testing equipment market. The fungal testing kits industry is regulated by device restrictions, illness epidemiology, and the rate of product acceptance, as well as the influence of macroeconomic and industrial factors. Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-12418 The development of low-cost kits, as well as increased attempts to raise awareness of fungal diseases, is a significant advancement in the fungal testing kits market.

Timing Trades in Hologic HOLX can be Risky if you Don''t Have Discipline

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #Globalwomanshealthindex--Hologic “Making a World of Difference” Through Global Sustainability Impact

Hologic (HOLX) said its V5 global endometrial ablation designed to treat a wide range of cervical and uterine anatomies had been approved in Canada and Europe. NovaSure V5 has a…

MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure® V5 global endometrial ablation (GEA) device in Canada and Europe. This innovative new version incorporates enhanced features designed to treat a wide range of cervical and uterine anatomies. It builds on a world-class track record for […]

Let''s review the charts and indicators….HOLX

https://www.investing.com/news/pro/hologic-pt-raised-to-81-at-morgan-stanley-432SI-2994451

Hologic (NASDAQ:HOLX) gained Thursday after reporting first-quarter earnings per share above expectations and previous guidance, according to FactSet. Hologic also said its revenue was in line with expectations for the quarter. Revenue of $1,074.2 …

Hologic, Inc. (NASDAQ:NASDAQ:HOLX) Q1 2023 Earnings Conference Call February 1, 2023 4:30 PM ETCompany ParticipantsRyan Simon - VP, IRStephen MacMillan - Chairman, President and CEOKarleen…

Hologic reported revenue of $1.1 billion for the quarter, slightly better than the FactSet analysts consensus estimate of $1 billion.

BEDFORD (dpa-AFX) - Hologic Inc (HOLX) revealed a profit for first quarter that decreased from the same period last year but beat the Street estimates.The company''s bottom line totaled $187.4 mill…

Hologic Inc. stock rose nearly 3% in the extended session Wednesday after the medical technology company reported quarterly earnings and sales that topped…

© Reuters. Hologic earnings beat by $0.16, revenue topped estimates Investing.com – Hologic (NASDAQ: HOLX) reported first quarter EPS of $1.07, $0.16 better than the analyst estimate of $0.91. Revenue for the quarter came in at $1.07B versus the consensus estimate of $997.31M. Guidance Hologic sees FY 2023 EPS of $2.51-$2.81 versus the analyst consensus […] The post Hologic earnings beat by $0.16, revenue topped estimates By Investing.com first appeared on Forex Trader Hub .

Hologic (NASDAQ: HOLX ) is set to give its latest quarterly earnings report on Wednesday, 2023-02-01. Here''s what investors need to know before the announcement. Analysts estimate that Hologic will report an earnings per share (EPS) of $0.82. Hologic bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com

Hologic was a beneficiary of the pandemic, catching a strong bid across that period. Read more to see why we reiterate that HOLX stock is a Buy.

HIV Diagnostics Test Market Research focuses on the key trends prevailing in the Global HIV Diagnostics Test Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market